-
16. Therapeutic apheresis of immune diseases in nephrology department.
Visvardis G, Manou E, Griveas I, Meimaridou D, Mitsopoulos E, Kyriklidou P, Papadopoulou D, Ginikopoulou E, Rottstein L, Sakellariou G.
Nephrology Departments, Papageorgiou General Hospital, Thessaloniki, Greece.
Ren Fail. 2004 Sep;26(5):569-74.
-
17. Lymphocytes subsets in the course of continuous ambulatory peritoneal dialysis (CAPD).
Griveas I, Visvardis G, Fleva A, Papadopoulou D, Mitsopoulos E, Nikopoulos K, Manou E, Kyriklidou P, Ginikopoulou E, Meimaridou D, Pavlitou A, Sakellariou G.
Nephrology Departments, Papageorgiou General Hospital, Thessaloniki, Greece.
Ren Fail. 2004 Nov;26(6):641-6.
-
18. Serum magnesium levels in hemodialysis patients receiving sevelamer hydrochloride.
I. Griveas, G. Visvardis, D. Papadopoulou, Ε. Μitsopoulos, P. Kyriklidou, Ε. Μanou, Ε. Ginikopoulou, D. Meimaridou, Α. Paulitou, G. Sakellariou.
Nephrology Departments, Papageorgiou General Hospital, Thessaloniki, Greece.
Hellen Nephrol 2005 ;17 (1) :73-79.
-
19. Thepapeutical plasmapheresis in stiff-man syndrome.
I. Griveas, G. Visvardis, D. Papadopoulou, Ε. Μitsopoulos, P. Kyriklidou, Ε. Μanou, Ε. Ginikopoulou, D. Meimaridou, Α. Paulitou, G. Sakellariou.
Nephrology Departments, Papageorgiou General Hospital, Thessaloniki, Greece.
Hellen Nephrol 2005 ;17 (4) :320-323.
-
20. Comparative analysis of immunophenotypic abnormalities in celllular immunity of uremic patients undergoing either haemodialysis or continuous ambulatory peritoneal dialysis.
I. Griveas, G. Visvardis, Α Fleva, D. Papadopoulou, Ε. Μitsopoulos, P. Kyriklidou, Ε. Μanou, Ε. Ginikopoulou, D. Meimaridou, Α. Paulitou, G. Sakellariou.
Nephrology Departments, Papageorgiou General Hospital, Thessaloniki, Greece.
Ren Fail. 2005;27(3):279-282 (cited in 10 articles).
